BEST1 is a Rare One
Downloads
Published
Keywords:
Mutation Mucrocornia StaphylomaDimensions Badge
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
© Author, Open Access. This article is licensed under a CC Attribution 4.0 License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/byncsa/4.0/.
MRCS syndrome caused by a BEST1 mutation, which was described in one family, is characterized by microcornea, rod–cone dystrophy, early-onset cataract, and posterior staphyloma. The present case aims to gather data on this rare genetic disorder and help pave the way for therapy in future. MRCS syndrome caused by a BEST1 mutation, which was described in one family, is characterized by microcornea, rod–cone dystrophy, earlyonset pulverulent cataract, and posterior staphylomaAt present, no definitive therapies or treatments exist for patients with bestrophinopathies. Investigation of MRCS syndrome in patients will promote better rehabilitation and monitoring of patients. An early treatment could help to avoid the effect of long term desensitization of optic nerve and amblyopiaAbstract
How to Cite
Downloads